Private finance: Cardior Pharmaceuticals, DiA Imaging Analysis, Elixiron Immunotherapeutics, Speclipse, EpiEndo Pharmaceuticals, Ranok Therapeutics

China: Ranok Therapeutics, an emerging biopharmaceutical company focused on developing therapies for cancer and other serious diseases, has secured a total of US$40m through a Series B funding round denominated in both dollars and Chinese yuan. The financing was led by Lapam Capital and Shanghai Healthcare Capital, with additional participation from Wu Capital, Zhongguancun Kaiyuan…